275 related articles for article (PubMed ID: 25976179)
1. Effects of Muscone on the Expression of P-gp, MMP-9 on Blood-Brain Barrier Model In Vitro.
Wang GY; Wang N; Liao HN
Cell Mol Neurobiol; 2015 Nov; 35(8):1105-15. PubMed ID: 25976179
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone regulation of P-glycoprotein activity in an immortalized rat brain endothelial cell line, GPNT.
Régina A; Romero IA; Greenwood J; Adamson P; Bourre JM; Couraud PO; Roux F
J Neurochem; 1999 Nov; 73(5):1954-63. PubMed ID: 10537053
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of TNF-α protects in vitro brain barrier from ischaemic damage.
Abdullah Z; Rakkar K; Bath PM; Bayraktutan U
Mol Cell Neurosci; 2015 Nov; 69():65-79. PubMed ID: 26546149
[TBL] [Abstract][Full Text] [Related]
4. Protection of Tong-Qiao-Huo-Xue Decoction against Cerebral Ischemic Injury through Reduction Blood-Brain Barrier Permeability.
Li L; Wang N; Jin Q; Wu Q; Liu Y; Wang Y
Chem Pharm Bull (Tokyo); 2017; 65(11):1004-1010. PubMed ID: 29093286
[TBL] [Abstract][Full Text] [Related]
5. Penetration of verapamil across blood brain barrier following cerebral ischemia depending on both paracellular pathway and P-glycoprotein transportation.
Fang W; Lv P; Geng X; Shang E; Yang Q; Sha L; Li Y
Neurochem Int; 2013 Jan; 62(1):23-30. PubMed ID: 23142723
[TBL] [Abstract][Full Text] [Related]
6. Silver nanoparticles induce tight junction disruption and astrocyte neurotoxicity in a rat blood-brain barrier primary triple coculture model.
Xu L; Dan M; Shao A; Cheng X; Zhang C; Yokel RA; Takemura T; Hanagata N; Niwa M; Watanabe D
Int J Nanomedicine; 2015; 10():6105-18. PubMed ID: 26491287
[TBL] [Abstract][Full Text] [Related]
7. Fructose-1,6-bisphosphate ameliorates lipopolysaccharide-induced dysfunction of blood-brain barrier.
Seok SM; Kim JM; Park TY; Baik EJ; Lee SH
Arch Pharm Res; 2013 Sep; 36(9):1149-59. PubMed ID: 23604722
[TBL] [Abstract][Full Text] [Related]
8. Ligustilide Ameliorates the Permeability of the Blood-Brain Barrier Model In Vitro During Oxygen-Glucose Deprivation Injury Through HIF/VEGF Pathway.
Wu S; Wang N; Li J; Wang G; Seto SW; Chang D; Liang H
J Cardiovasc Pharmacol; 2019 May; 73(5):316-325. PubMed ID: 30855407
[TBL] [Abstract][Full Text] [Related]
9. Hyperammonemia enhances the function and expression of P-glycoprotein and Mrp2 at the blood-brain barrier through NF-κB.
Zhang J; Zhang M; Sun B; Li Y; Xu P; Liu C; Liu L; Liu X
J Neurochem; 2014 Dec; 131(6):791-802. PubMed ID: 25200138
[TBL] [Abstract][Full Text] [Related]
10. Influence of borneol and muscone on geniposide transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model.
Chen ZZ; Lu Y; Du SY; Shang KX; Cai CB
Int J Pharm; 2013 Nov; 456(1):73-9. PubMed ID: 23973509
[TBL] [Abstract][Full Text] [Related]
11. Role of matrix metalloproteinase-2/9 (MMP2/9) in lead-induced changes in an
Liu X; Su P; Meng S; Aschner M; Cao Y; Luo W; Zheng G; Liu M
Int J Biol Sci; 2017; 13(11):1351-1360. PubMed ID: 29209140
[TBL] [Abstract][Full Text] [Related]
12. The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.
Shan Y; Tan S; Lin Y; Liao S; Zhang B; Chen X; Wang J; Deng Z; Zeng Q; Zhang L; Wang Y; Hu X; Qiu W; Peng L; Lu Z
J Neuroinflammation; 2019 Nov; 16(1):242. PubMed ID: 31779652
[TBL] [Abstract][Full Text] [Related]
13. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes.
Gaillard PJ; Voorwinden LH; Nielsen JL; Ivanov A; Atsumi R; Engman H; Ringbom C; de Boer AG; Breimer DD
Eur J Pharm Sci; 2001 Jan; 12(3):215-22. PubMed ID: 11113640
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-β.
Shao B; Bayraktutan U
Diabetes Obes Metab; 2013 Nov; 15(11):993-9. PubMed ID: 23617822
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of urokinase activity during experimental ischaemia protects the cerebral barrier from damage through regulation of matrix metalloproteinase-2 and NAD(P)H oxidase.
Rakkar K; Srivastava K; Bayraktutan U
Eur J Neurosci; 2014 Jun; 39(12):2119-28. PubMed ID: 24649947
[TBL] [Abstract][Full Text] [Related]
16. The extracellular matrix protein laminin-10 promotes blood-brain barrier repair after hypoxia and inflammation in vitro.
Kangwantas K; Pinteaux E; Penny J
J Neuroinflammation; 2016 Feb; 13():25. PubMed ID: 26832174
[TBL] [Abstract][Full Text] [Related]
17. Alteration in P-glycoprotein at the blood-brain barrier in the early period of MCAO in rats.
Cen J; Liu L; Li MS; He L; Wang LJ; Liu YQ; Liu M; Ji BS
J Pharm Pharmacol; 2013 May; 65(5):665-72. PubMed ID: 23600383
[TBL] [Abstract][Full Text] [Related]
18. The role of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury.
Higashida T; Kreipke CW; Rafols JA; Peng C; Schafer S; Schafer P; Ding JY; Dornbos D; Li X; Guthikonda M; Rossi NF; Ding Y
J Neurosurg; 2011 Jan; 114(1):92-101. PubMed ID: 20617879
[TBL] [Abstract][Full Text] [Related]
19. Effects of fasudil on blood-brain barrier integrity.
Sato K; Nakagawa S; Morofuji Y; Matsunaga Y; Fujimoto T; Watanabe D; Izumo T; Niwa M; Walter FR; Vigh JP; Santa-Maria AR; Deli MA; Matsuo T
Fluids Barriers CNS; 2022 Jun; 19(1):43. PubMed ID: 35659272
[TBL] [Abstract][Full Text] [Related]
20. [Effect of lysophosphatidic acid increase the permeability of blood-brain barrier model].
Gan N; Yin F; Peng J; Wang WD
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):416-8. PubMed ID: 18581898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
